InvestorsHub Logo

H2R

Followers 42
Posts 2155
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: H2R post# 1421

Wednesday, 08/02/2017 9:15:36 PM

Wednesday, August 02, 2017 9:15:36 PM

Post# of 1569
The financials look good!

Second Quarter 2017 Financial Results


SOUTH SAN FRANCISCO, Calif., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) reported total revenues for the second quarter of 2017 were $3.1 million, compared to $5.8 million, during the same period in 2016. Net loss for the second quarter was $29.1 million, or $0.60 per share, respectively, compared to a net loss for the same period in 2016 of $11.6 million, or $0.29 per share. As of June 30, 2017, cash, cash equivalents and investments totaled $332.1 million.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYTK News